Not recruitingISRCTN54096201
Effects and mechanisms of psychotherapy in the treatment of attention deficit hyperactivity disorder in adults: the first multicentre study
This study isn't currently recruiting.
In GermanyADHDResearch study
ADHD studies
ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT00269789
A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for Attention Deficit Hyperactivity Disorder in Children
Official study title
Comparative Crossover Study of OROS (Methylphenidate HCl), Ritalin, and Placebo in Children With ADHD
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–12
CompletedNCT00429091
A Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers compared ABT-894, placebo and atomoxetine, tracking side effects to assess safety in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including San FranciscoADHDMedication studyAges 18–60
CompletedNCT00391729
A Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers compared ABT-089 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaADHDMedication studyAges 18–60
CompletedNCT00969618
A Long Term Follow-Up Study for Asian adults with Attention Deficit Hyperactivity Disorder
What is this study about?
Researchers studied atomoxetine, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including AichiADHDMedication studyAges 18+
CompletedNCT00269802
OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo for ADHD
What is this study about?
Researchers compared OROS methylphenidate HCl, Ritalin and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–12
WithdrawnNCT00323700
A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)
Official study title
A Naturalistic Prospective Study of Treatment Effectiveness for ADHD
This study was withdrawn before enrollment.
Location not clearly listedADHDObservational studyAges 16–18
CompletedNCT00190775
A Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including IrvineADHDMedication studyAges 18+
CompletedNCT00528697
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers compared ABT-089, atomoxetine and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–12
CompletedNCT00443391
A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
What is this study about?
Researchers studied ABT-089, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaADHDMedication studyAges 18–60
TerminatedNCT00554385
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
What is this study about?
Researchers are studying ABT-089 to find out how it affects ADHD symptoms in children with ADHD.
This study ended early.
Multiple locations, including Little RockADHDMedication studyAges 6–12
CompletedNCT00447278
A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
Official study title
A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including BrusselsADHDMedication studyAges 6–16
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.